Vir Biotechnology Inc (VIR) Stock Forecast & Price Target
Vir Biotechnology Inc · NASDAQ
$11.18-0.20 (-1.80%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 6 firms covering Vir Biotechnology Inc, 6 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $18.00 to $30.00, a moderate spread. The average target of $22.33 sits 100% above the current $11.18. The rating mix has stayed broadly stable, with Buy-side ratings easing from 8 to 6 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.63 next quarter toward $-2.49 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 ratings
Strong Buy
Strong Buy00%
Buy6100%
Hold00%
Sell00%
Strong Sell00%
Based on 6 analysts giving stock ratings to Vir Biotechnology Inc.
As of Sep, 6 of 6 firms rate VIR a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
VIR EPS & revenue forecast
EPS · NEXT QUARTER
$-0.63
Range $-0.78 – $-0.49 · 7 analysts · +103% YoY
Next period, 7 analysts expect Vir Biotechnology Inc to earn $-0.63 a share (range $-0.78 – $-0.49), versus $-0.31 a year earlier. Full-year consensus is $-1.76, growing to $-2.49 the year after.
REVENUE · NEXT QUARTER
$6.3M
Range $11.0K – $19.8M · 7 analysts · -90% YoY
Revenue is expected to reach $6.3M (range $11.0K – $19.8M), -90.2% year-over-year. Full-year consensus is $245.2M, rising to $73.6M next year.
Top analysts covering Vir Biotechnology Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on VIR.
#1
Joseph Stringer
Needham · Rank #195
Buy
$18.00+61.0% to target
Overall win rate
36%
+ Follow
#2
Patrick R. Trucchio
HC Wainwright & Co. · Rank #230
Buy
$20.00+78.9% to target
Overall win rate
36%
+ Follow
#3
Roanna Ruiz
SVB Leerink · Rank #388
Buy
$19.00+69.9% to target
Overall win rate
31%
+ Follow
#4
Cory Kasimov
Evercore ISI Group
Buy
$22.00+96.8% to target
Coverage
—
+ Follow
#5
MG
Michelle Gilson
Morgan Stanley
Buy
$27.00+141.5% to target
Coverage
—
+ Follow
VIR stock forecast FAQ
What is VIR's average 12-month price target?+
The 6 analysts with a live target average $22.33 for Vir Biotechnology Inc over the next 12 months, ranging from a $30.00 high to a $18.00 low.
Is VIR stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 6 analyst ratings, 6 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for VIR?+
The Street-high target is $30.00 (Barclays), and the Street-low is $18.00 (Evercore ISI Group). The average of all 6 active targets is $22.33.
How many Wall Street analysts cover VIR?+
6 analysts have an active rating on Vir Biotechnology Inc, and 6 firms carry a live 12-month price target.
Who is the most accurate analyst covering VIR?+
Among analysts who currently cover VIR, Joseph Stringer of Needham has the strongest overall Quantellect track record (Rank #195). Their current call is Buy with a $18.00 target.
What is Vir Biotechnology Inc's projected EPS for next quarter?+
The consensus estimate is $-0.63 per share (range $-0.78 – $-0.49) across 7 analysts. Full-year EPS is projected at $-1.76, rising to $-2.49 the following year.
How much revenue is Vir Biotechnology Inc expected to report next quarter?+
Consensus revenue is $6.3M (range $11.0K – $19.8M). Full-year revenue is projected at $245.2M, growing to $73.6M next year.
Have analysts been upgrading or downgrading VIR lately?+
As of Sep, 6 of 6 firms rate VIR a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their VIR calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
